Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Elizabeth B Elimimian"'
Publikováno v:
Breast Cancer: Basic and Clinical Research, Vol 14 (2020)
Background: Guidelines regarding the usage of adjuvant systemic therapy in patients with small human epidermal growth factor receptor 2 (HER2)-positive and estrogen receptor/progesterone receptor–positive (luminal HER2 positive) tumors are nonspeci
Externí odkaz:
https://doaj.org/article/2fc6fd15b80246518f8839cb686bf92d
Publikováno v:
Indian Journal of Ophthalmology, Vol 66, Iss 1, Pp 9-9 (2018)
Externí odkaz:
https://doaj.org/article/be3a0dbf698c439e8730f9691a73b480
Autor:
Carol L Shields, Elizabeth B Elimimian
Publikováno v:
Indian Journal of Ophthalmology, Vol 66, Iss 3, Pp 359-359 (2018)
Externí odkaz:
https://doaj.org/article/f3e33237b1ae412fb76bd10b12d89738
Publikováno v:
Journal of Cancer Epidemiology, Vol 2020 (2020)
Introduction. Breast cancer remains the most commonly diagnosed malignancy in women. It encompasses considerable heterogeneity in pathology, patient clinical characteristics, and outcome. This study describes factors associated with overall survival
Externí odkaz:
https://doaj.org/article/69997e098d2c4048882552d44294e86e
Autor:
Elizabeth B. Elimimian, Leah Elson, Hong Li, Hong Liang, Nadeem Bilani, Emily C. Zabor, Abby Statler, Zeina Nahleh
Publikováno v:
The World Journal of Men's Health
The World Journal of Men's Health, Vol 39, Iss 3, Pp 506-515 (2021)
The World Journal of Men's Health, Vol 39, Iss 3, Pp 506-515 (2021)
Purpose: Breast cancer (BC) in males accounts for 10% lower at 5-years and nearly 20% lower at 10-years for males. More males had primary BC tumors under the nipple; the 10-year OS rate for this site was 48.8%. Conclusions:Conclusions: This study rep
Autor:
Elizabeth B. Elimimian, Leah Elson, Hong Li, Hong Liang, Nadeem Bilani, Emily C. Zabor, Abby Statler, Zeina Nahleh
Publikováno v:
The World Journal of Men's Health, Vol 39, Iss 3, Pp 506-515 (2021)
Purpose: Breast cancer (BC) in males accounts for 10% lower at 5-years and nearly 20% lower at 10-years for males. More males had primary BC tumors under the nipple; the 10-year OS rate for this site was 48.8%. Conclusions:Conclusions: This study rep
Externí odkaz:
https://doaj.org/article/37b0aa55dd4347e58f472764d9520ed8